Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Military Medicine|February 20, 2020
Army Antimalarial Drug Development: An Advanced Development Case Study for TafenoquineVictor E Zottig, Katherine A Carr, John G Clarke, et al.Journal of the American Chemical Society|October 4, 2011
[4 + 2] Cyclocondensation reactions of tungsten-dihydropyridine complexes and the generation of tri- and tetrasubstituted piperidinesDaniel P Harrison, Diana A Iovan, William H Myers, et al.Stress (Amsterdam, Netherlands)|February 17, 2018
Developmental differences in stress responding after repeated underwater trauma exposures in ratsDaniel E Altman, Laurence P Simmons, Chau T Vuong, et al.Travel Medicine and Infectious Disease|November 21, 2021
Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trialAnne Novitt-Moreno, Adam Martidis, Victor Gonzalez, et al.Malaria Journal|January 7, 2014
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compoundsSean R Marcsisin, Jason C Sousa, Gregory A Reichard, et al.Antimicrobial Agents and Chemotherapy|April 15, 2015
Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokineticsChau Vuong, Lisa H Xie, Brittney M J Potter, et al.Antimicrobial Agents and Chemotherapy|February 4, 2015
Differential CYP 2D6 metabolism alters primaquine pharmacokineticsBrittney M J Potter, Lisa H Xie, Chau Vuong, et al.Pageof 1